Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $36.46, for a total value of $72,920.00. Following the sale, the chief executive officer owned 182,952 shares of the company’s stock, valued at approximately $6,670,429.92. This represents a 1.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Friday, October 9th, Margaret Tooth sold 1,000 shares of Trupanion stock. The shares were sold at an average price of $25.84, for a total value of $25,840.00.
- On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The stock was sold at an average price of $25.00, for a total value of $25,000.00.
- On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total value of $15,633.44.
Trupanion Stock Performance
TRUP stock traded up $0.18 during trading hours on Friday, hitting $34.48. 239,749 shares of the stock were exchanged, compared to its average volume of 457,454. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $1.49 billion, a P/E ratio of 56.52, a P/E/G ratio of 1.58 and a beta of 1.27. The company has a 50-day simple moving average of $27.72 and a two-hundred day simple moving average of $26.75. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $38.98.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. The company had revenue of $405.59 million during the quarter, compared to the consensus estimate of $402.53 million. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. During the same quarter last year, the firm earned $0.13 earnings per share. On average, analysts forecast that Trupanion, Inc. will post 0.68 earnings per share for the current fiscal year.
Institutional Trading of Trupanion
Several large investors have recently modified their holdings of the stock. First Trust Advisors LP lifted its position in Trupanion by 52.9% during the third quarter. First Trust Advisors LP now owns 83,490 shares of the financial services provider’s stock worth $1,950,000 after purchasing an additional 28,903 shares during the period. Landscape Capital Management L.L.C. grew its stake in Trupanion by 27.8% during the third quarter. Landscape Capital Management L.L.C. now owns 132,191 shares of the financial services provider’s stock worth $3,088,000 after buying an additional 28,736 shares in the last quarter. Fifth Third Bancorp grew its stake in Trupanion by 4.0% during the third quarter. Fifth Third Bancorp now owns 7,772 shares of the financial services provider’s stock worth $182,000 after buying an additional 302 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in Trupanion by 22.8% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 20,635 shares of the financial services provider’s stock valued at $482,000 after buying an additional 3,833 shares during the period. Finally, Oregon Public Employees Retirement Fund increased its holdings in Trupanion by 7.7% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 8,359 shares of the financial services provider’s stock valued at $195,000 after buying an additional 600 shares during the period.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on TRUP. Wall Street Zen raised shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. Stifel Nicolaus lifted their price target on shares of Trupanion from $29.00 to $34.00 and gave the company a “hold” rating in a research report on Monday, November 9th. Finally, Weiss Ratings upgraded Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $40.00.
Read Our Latest Analysis on TRUP
About Trupanion
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
Read More
- Five stocks we like better than Trupanion
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
